Medicare Enrolled

Dr. Tamam Mohamad

Cardiovascular Disease · Detroit, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
4160 JOHN R ST STE 510, Detroit, MI 48201
3139937777
In practice since 2009 (16 years)
NPI: 1457687584 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mohamad from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mohamad? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mohamad

Dr. Tamam Mohamad is a cardiovascular disease specialist in Detroit, MI, with 16 years of NPI registration. Based on federal Medicare data, Dr. Mohamad performed 12,538 Medicare services across 4,837 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mohamad received a total of $1,107,801 from 73 pharmaceutical and/or device companies across 1570 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mohamad is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 1% volume in MI $1,107,801 industry payments

Medicare Practice Summary

Medicare Utilization ↗
12,538
Medicare services
Top 1% in MI for cardiovascular disease
4,837
Unique beneficiaries
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~784 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Contrast dye for imaging, lower concentration 4,503 $0 $2
Regadenoson injection (Lexiscan) for heart stress test
An injection of regadenoson, a medication used to stress the heart during diagnostic testing.
1,083 $43 $258
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
741 $66 $226
Chronic care management, first 20 min/month
This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions.
732 $50 $160
Technetium Tc-99m sestamibi diagnostic injection
A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies.
574 $102 $200
Remote patient monitoring management, 20 min/month
Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month.
406 $39 $124
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
318 $10 $52
Echocardiogram, transthoracic
An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function.
317 $135 $495
Chronic care management, additional 20 min/month
This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month.
316 $37 $124
Remote vital sign monitoring management, each additional 20 minutes
This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period.
288 $31 $101
Nuclear stress test of heart muscle
A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera.
287 $335 $1,102
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
236 $143 $460
Ultrasound of head and neck blood flow, bilateral
An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck.
202 $131 $477
Ultrasound of leg arteries or grafts
An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present.
195 $175 $596
Ultrasound of arm or leg veins
An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers.
179 $133 $478
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
178 $21 $68
Lung volume test using gas dilution or washout
A test that measures the amount of air in your lungs by using a gas dilution or washout method.
166 $34 $110
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
166 $45 $142
Continuous ECG monitoring, up to 30 days
Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results.
161 $20 $66
Remote patient monitoring device, 30 days
Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period.
160 $39 $125
30-day continuous ECG with patient-triggered event transmission and review
This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report.
116 $657 $2,113
Additional sedation, per 15 minutes
Administration of a drug to deepen sedation during a procedure. This code covers each additional 15-minute increment of sedation beyond the initial period.
109 $9 $35
Ultrasound of arm and leg arteries
A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues.
103 $81 $325
Remote physiological data monitoring, 30 days
Collection and interpretation of physical parameters transmitted by the patient or caregiver over a 30-day period, requiring at least 30 minutes of professional time.
92 $44 $140
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
89 $103 $317
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
85 $84 $287
Principal care management for high-risk disease, first 30 minutes
This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional.
85 $49 $157
Remote physiologic monitoring setup and education
Initial setup of remote monitoring equipment and patient education on its use.
72 $15 $49
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
50 $64 $203
Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts
A complete ultrasound exam of the aorta, vena cava, groin vessels, or bypass grafts. This imaging test uses sound waves to visualize these blood vessels.
43 $119 $452
Sedation by physician, initial 15 minutes
Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older.
41 $40 $154
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
37 $8 $19
Ultrasound of arm or leg veins
An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages.
36 $84 $303
Additional blood vessel ultrasound evaluation
An ultrasound exam of a blood vessel that includes a radiologist's review. This code applies to each additional vessel evaluated beyond the initial one.
34 $140 $536
Ultrasound of blood vessel, initial vessel
An ultrasound exam of a blood vessel that includes a radiologist's review of the initial vessel.
28 $764 $2,947
Radiologist review of arm or leg artery images
A radiologist reviews images of the arteries in one or both arms or legs to assess blood flow and vessel health.
28 $132 $2,482
Coronary angiography
A procedure to insert a tube into a coronary artery to capture diagnostic images of the heart's blood vessels.
26 $178 $510
Radiofrequency vein destruction, first vein
A procedure to treat the first incompetent vein in the arm or leg using radiofrequency energy and imaging guidance.
25 $869 $2,785
Basic blood chemical test (calcium, ionized)
A blood test that measures basic chemical levels, specifically including calcium and ionized calcium.
24 $13 $41
Red blood cell concentration measurement
A laboratory test that measures the concentration of red blood cells in the blood.
24 $2 $7
Hemoglobin blood test
A blood test that measures the amount of hemoglobin, the protein in red blood cells that carries oxygen.
24 $2 $7
Chemical destruction of first incompetent vein with imaging guidance
This procedure uses imaging guidance to chemically destroy the first incompetent vein in the arm or leg.
22 $1,311 $4,252
Cardiac catheterization 20 $221 $623
Arterial plaque removal in leg
A procedure to remove plaque buildup from the arteries in the leg to restore blood flow.
19 $7,001 $27,138
Drug infusion during cardiac catheterization
Administration of medication through a catheter inserted into the heart during a cardiac catheterization procedure.
17 $79 $203
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
15 $141 $443
Additional 30 minutes of principal care management
This service covers each additional 30 minutes of clinical staff time directed by a healthcare professional for managing a single high-risk disease, billed per calendar month.
15 $38 $122
Exercise or drug-induced heart stress test with ECG
A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review.
14 $46 $177
New patient office visit, 15-29 minutes
An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold.
13 $49 $181
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
12 $28 $147
Aminophylline injection, up to 250 mg
Administration of aminophylline medication via injection for a dose of up to 250 mg.
12 $7 $20
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.2% high complexity
58.0% medium
38.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,107,801
Total received (2018-2024)
Avg $158,257/year across 7 years
Top 0% in MI for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
73
Companies
1,570
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,069,690 (96.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,350 (1.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$12,181 (1.1%)
Other
Charitable contributions, space rental, and other categories
$11,580 (1.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$134,678
2023
$112,672
2022
$185,512
2021
$126,746
2020
$85,208
2019
$212,959
2018
$250,026

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Bayer Healthcare Pharmaceuticals Inc.
$36,699
Boehringer Ingelheim Pharmaceuticals, Inc.
$33,107
Novo Nordisk Inc
$20,742
Lilly USA, LLC
$10,501
Medtronic, Inc.
$9,431
AngioDynamics, Inc.
$7,519
TACTILE SYSTEMS TECHNOLOGY INC
$4,746
Janssen Pharmaceuticals, Inc
$4,689
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$4,208
Tactile Systems Technology Inc
$601
Recor Medical Inc
$423
Novartis Pharmaceuticals Corporation
$333
Kestra Medical Technology Services, Inc.
$245
Merck Sharp & Dohme LLC
$164
Innova Vascular Inc.
$160
Boston Scientific Corporation
$147
ABIOMED
$135
AstraZeneca Pharmaceuticals LP
$131
Kiniksa Pharmaceuticals International, plc
$96
Impulse Dynamics (USA) Inc.
$96
American Regent
$82
Actelion Pharmaceuticals US, Inc.
$80
Penumbra, Inc.
$66
PFIZER INC.
$61
CORDIS US CORP.
$37
E.R. Squibb & Sons, L.L.C.
$32
Getinge USA Sales, LLC
$31
Amgen Inc.
$28
Daiichi Sankyo Inc.
$24
United Therapeutics Corporation
$18
SCPHARMACEUTICALS INC.
$16
Lexicon Pharmaceuticals, Inc.
$15
GlaxoSmithKline, LLC.
$15
Top 3 companies account for 67.2% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$283,753
Janssen Pharmaceuticals, Inc
$241,444
Novo Nordisk Inc
$172,228
Lilly USA, LLC
$130,615
Novartis Pharmaceuticals Corporation
$66,766
Medtronic, Inc.
$59,535
Bayer Healthcare Pharmaceuticals Inc.
$38,188
Relypsa, Inc.
$33,721
Medtronic Vascular, Inc.
$19,270
AngioDynamics, Inc.
$11,615
Venclose Inc.
$10,541
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$10,164
ABIOMED
$5,236
Eli Lilly and Company
$5,000
TACTILE SYSTEMS TECHNOLOGY INC
$4,746
AstraZeneca Pharmaceuticals LP
$2,828
GlaxoSmithKline, LLC.
$1,423
Boston Scientific Corporation
$1,179
Tactile Systems Technology Inc
$894
PFIZER INC.
$697
Cardiovascular Systems Inc.
$676
Terumo Medical Corporation
$546
Kestra Medical Technology Services, Inc.
$531
Abbott Laboratories
$522
Merck Sharp & Dohme LLC
$511
Amgen Inc.
$471
Recor Medical Inc
$423
Cardinal Health 200, LLC
$362
Actelion Pharmaceuticals US, Inc.
$266
Cardinal Health 200 LLC
$257
Inari Medical, Inc.
$251
Philips Electronics North America Corporation
$248
CathWorks, Inc.
$244
Bayer HealthCare Pharmaceuticals Inc.
$230
E.R. Squibb & Sons, L.L.C.
$189
Astellas Pharma US Inc
$175
Innova Vascular Inc.
$160
BOSTON SCIENTIFIC CORPORATION
$146
Edwards Lifesciences Corporation
$139
CORDIS US CORP.
$128
Ablative Solutions, Inc.
$123
TRUVIC MEDICAL, INC.
$100
Kiniksa Pharmaceuticals International, plc
$96
Impulse Dynamics (USA) Inc.
$96
Baxter Healthcare
$91
American Regent
$82
Penumbra, Inc.
$75
Preventice Services, LLC
$61
CARDIVA MEDICAL, INC.
$54
Lexicon Pharmaceuticals, Inc.
$54
Kiniksa Pharmaceuticals, Ltd.
$52
CVRx, Inc.
$51
Amarin Pharma Inc.
$46
Alnylam Pharmaceuticals Inc.
$45
Gilead Sciences, Inc.
$44
Daiichi Sankyo Inc.
$42
United Therapeutics Corporation
$37
Bard Peripheral Vascular, Inc.
$33
Getinge USA Sales, LLC
$31
Merck Sharp & Dohme Corporation
$29
ARALEZ PHARMACEUTICALS US INC.
$28
Otsuka America Pharmaceutical, Inc.
$27
SANOFI-AVENTIS U.S. LLC
$27
ConvaTec Inc.
$19
Corcept Therapeutics
$18
EKOS Corporation
$18
Ultragenyx Pharmaceutical Inc.
$18
Imperative Care, Inc
$18
SCPHARMACEUTICALS INC.
$16
Bardy Diagnostics, Inc.
$15
ARGON MEDICAL DEVICES, INC.
$13
Chiesi USA, Inc.
$11
ARBOR PHARMACEUTICALS, INC.
$11
Top 3 companies account for 63.0% of all-time payments
Associated products mentioned in payments ›
(9281) Turbo Elite · ABRE · ALPHAVAC · ANGIO-SEAL · ANGIOJET · ANORO · ANORO ELLIPTA · AQUACEL AG+ EXTRA · AURYON LASER SYSTEM 100-120 VAC · AVVIGO Guidance System · Aimovig · AngioJet XMI · Arcalyst · Assure WCD · Auryon Laser System 100-120 Vac · BRILINTA · BRITE TIP RADIANZ · Barostim Neo System · Bidil · BodyGuardian · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE 6/7F VCS · CARDIVA VASCADE MVP VVCS 6-12F · CHANTIX · CLOSUREFAST · COROFLOW · CardioMEMS HF System · CareLink · Carnation Ambulatory Monitor · Claria MRI · ClosureFast · Corlanor · Coronary Orbital Atherectomy System · DIAMONDBACK CORONARY · Diamondback Peripheral · EKOSONIC · ELIQUIS · EMBLEM · EMBLEM MRI S-ICD · ENTRESTO · EVRSF · Edwards SAPIEN 3 Transcatheter Heart Valve · EkoSonic · FARXIGA · FFRANGIO · FLEXITOUCH · FLEXITOUCH PLUS · FLOWTRIEVER CATHETER · FRONTRUNNER XP CTO Catheter · FUROSCIX · Flexitouch Plus · GENERAL - THERAPIES · GENERAL METALLIC STENTS · GENERAL PAIN MANAGEMENT · GENERAL VASCULAR INTERVENTION · GLIDESHEATH SLENDER · General - Balloons · General - Therapies · General - Vascular Intervention · HAWKONE · HawkOne · HeartMate 3 Left Ventricular Assist Device · Hillrom - Cardiac Ambulatory Monitor · IGT_D Coronary · IGT_D Peripheral · ILARIS · INJECTAFER · Image Guided Therapy Devices _ Coronary · Impella · InPen · Indigo · Indigo System · Inpefa · JARDIANCE · KENGREAL · Kerendia · Korlym · LEQVIO · LEXISCAN · LINQ II · LUX-Dx Insertable Cardiac Monitor · LifeVest · MOUNJARO · MYCARELINK · MYNX CONTROLTM · MYNXGRIP · MynxGrip Vascular Closure Device · NAVICROSS · ONPATTRO · OPSUMIT · OPTION · OUTBACK LTD Re-Entry Catheter · Optimizer · Ozempic · PARADISE RENAL DENERVATION SYSTEM · POWERFLEX Pro PTA Catheter · PRADAXA · PRALUENT · PRODIGY CATHETER · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · Peripheral RotaLink Plus · RAIN SHEATH · RYBELSUS · Repatha · Rybelsus · S · SABER · SAMSCA · TRELEGY ELLIPTA · TRULICITY · TURBOHAWK · TYVASO · UPTRAVI · VENACURE 1470 PRO · VENASEAL · VENOUS WALLSTENT · VERQUVO · VYNDAQEL · Vascepa · Veltassa · VenaSeal · Venclose · Visia AF · WALLSTENT · WALLSTENT RP Endoprosthesis · Wegovy · XARELTO · ZEPHYR · ZONTIVITY · iCAST
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (97%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for cardiovascular disease in MI.

Looking for a cardiovascular disease specialist in Detroit?
Compare cardiologists in the Detroit area by procedure volume, costs, and industry payment transparency.
Browse cardiologists nearby

Geographic Context

Cardiologists within 10 mi
305
Per 100K population
17.2
County median income
$59,521
Nearest hospital
HARPER UNIVERSITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mohamad is a clinical cardiology specialist, with above-average Medicare volume (top 1% in MI), with speaking/promotional industry engagement in the top 0% of MI peers, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mohamad experienced with contrast dye for imaging, lower concentration?
Based on Medicare claims data, Dr. Mohamad performed 4,503 contrast dye for imaging, lower concentration services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mohamad receive payments from pharmaceutical companies?
Yes. Dr. Mohamad received a total of $1,107,801 from 73 companies across 1,570 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mohamad's costs compare to other cardiologists in Detroit?
Dr. Mohamad's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mohamad) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →